Tempest Therapeutics, Inc.: which funds bought and sold
Institutions that bought and sold Tempest Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 8 institutions that filed 13F reports for both quarters added to or opened positions in Tempest Therapeutics, and 8 cut or closed them. Together they added a net 507K shares, +98.1% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 17K shares (+52.7%); index fund managers were net buyers of 5,718 shares (+1.3%). 4 opened a new position and 5 sold out entirely.
Bought, Q2 2026 8 institutions, 4 of them new holders Sold, Q2 2026 8 institutions, 5 of them sold out
Net change, all compared +507K shares (+98.1%)
Net change, active managers +17K shares (+52.7%), 2 bought, 1 sold
Buyers versus sellers
8 bought 8 8 sold
Active managers and hedge funds 2 bought · 1 sold · +17K
Index fund managers 1 bought · 1 sold · +5,718
Other institutions 5 bought · 6 sold · +484K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Sabby Management, LLC | +493K +2763.4% | 511K | $567,527 |
| Squarepoint Ops LLC Hedge fund | +31K New position | 31K | $34,299 |
| Citadel Advisors LLC Hedge fund | +20K New position | 20K | $22,000 |
| Northern Trust Corp Index funds | +6,083 +43.3% | 20K | $22,351 |
| Tower Research Capital LLC (TRC) | +1,132 +40.6% | 3,922 | $4,353 |
| UBS Group AG | +1,103 +24.3% | 5,636 | $6,255 |
| Barclays PLC | +222 New position | 222 | $246 |
| Caitong International Asset Management Co., Ltd | +3 New position | 3 | $3 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Squarepoint Ops LLC Hedge fund | +31K New position | 31K | $34,299 |
| Citadel Advisors LLC Hedge fund | +20K New position | 20K | $22,000 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| FMR LLC Active manager | −33K Sold out | 0 | — |
| Dimensional Fund Advisors LP | −11K Sold out | 0 | — |
| Geode Capital Management, LLC Index funds | −365 −0.4% | 87K | $96,155 |
| Vanguard Global Advisers, LLC | −168 Sold out | 0 | — |
| Morgan Stanley | −36 −1.7% | 2,022 | $2,244 |
| Osaic Holdings, Inc. | −16 −1.0% | 1,513 | $1,669 |
| Citigroup Inc | −8 Sold out | 0 | — |
| Jpmorgan Chase & Co | −5 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| FMR LLC Active manager | −33K Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Squarepoint Ops LLCHedge fund | 31K | $34,299 |
| Citadel Advisors LLCHedge fund | 20K | $22,000 |
| Barclays PLC | 222 | $246 |
| Caitong International Asset Management Co., Ltd | 3 | $3 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| FMR LLCActive manager | 33K | $54,489 |
| Dimensional Fund Advisors LP | 11K | $18,768 |
| Vanguard Global Advisers, LLC | 168 | $276 |
| Citigroup Inc | 8 | $13 |
| Jpmorgan Chase & Co | 5 | $8 |
Who holds the shares
- Institutions reporting
- 19
- Ten largest holders
- 99.6% of 13F-reported shares
- Index fund managers
- 43.8% of 13F-reported shares
- Active managers and hedge funds
- 5.0% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 2 | 1 | 2 | 1 | +17K | +52.7% |
| Index fund managers | 1 | 1 | 0 | 0 | +5,718 | +1.3% |
| Other institutions | 5 | 6 | 2 | 4 | +484K | +1181.0% |
← Back to Tempest Therapeutics, Inc. · Insiders · Politicians